Epoxyeicosatrienoic Acid-Based Therapy Attenuates the Progression of Postischemic Heart Failure in Normotensive Sprague-Dawley but Not in Hypertensive Ren-2 Transgenic Rats

Number of the records: 1

1.

SYSNO	0504092
Title	Epoxyeicosatrienoic Acid-Based Therapy Attenuates the Progression of Postischemic Heart Failure in Normotensive Sprague-Dawley but Not in Hypertensive Ren-2 Transgenic Rats
Author(s)	Hrdlička, Jaroslav (FGU-C)_{ORCID, RID} Neckář, Jan (FGU-C)_{RID, ORCID} Papoušek, František (FGU-C) Husková, Z. (CZ) Kikerlová, S. (CZ) Vaňourková, Z. (CZ) Vernerová, Z. (CZ) Akat, Firat (FGU-C) Vašinová, Jana (FGU-C) Hammock, B.D. (US) Hwang, S.H. (US) Imig, J. D. (US) Falck, J. R. (US) Červenka, L. (CZ) Kolář, František (FGU-C)_{RID, ORCID, SAI}
Corespondence/senior	Neckář, Jan - Korespondující autor
Source Title	Frontiers in Pharmacology. Roč. 10, Mar 1 (2019). - : Frontiers Media
Article number	159
Document Type	Článek v odborném periodiku
Grant	NV15-27735A GA MZd - Ministry of Health (MZ), CZ - Czech Republic
Institutional support	FGU-C - RVO:67985823
Language	eng
Country	CH
Keywords	epoxyeicosatrienoic acid * soluble epoxide hydrolase * chronic heart failure * hypertension * myocardial infarction * echocardiography
Cooperating institutions	Univerzita Karlova v Praze, Přírodovědecká fakulta (Czech Republic) Institut klinické a experimentální medicíny (Czech Republic)
URL	https://doi.org/10.3389/fphar.2019.00159
Permanent Link	http://hdl.handle.net/11104/0295795

Number of the records: 1